Sonoma Pharmaceuticals
SNOA
#10906
Rank
NZ$11.69 M
Marketcap
NZ$2.44
Share price
15.20%
Change (1 day)
-52.41%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -NZ$4.16 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$19.52 Million. In 2025 the company made an earning of -NZ$4.7 Million, an increase over its 2024 earnings that were of -NZ$7.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$4.16 Million-11.35%
2025 -NZ$4.7 Million-38.02%
2024 -NZ$7.58 Million0.54%
2023 -NZ$7.53 Million-31.5%
2022 -NZ$11 Million16.86%
2021 -NZ$9.41 Million194.32%
2020 -NZ$3.2 Million-58.76%
2019 -NZ$7.75 Million-65.66%
2018 -NZ$22.57 Million4.84%
2017 -NZ$21.53 Million-2.17%
2016 -NZ$22.01 Million32.12%
2015 -NZ$16.66 Million-307.74%
2014 NZ$8.01 M-197.5%
2013 -NZ$8.23 Million
2010 -NZ$12.85 Million-14.02%
2009 -NZ$14.95 Million-57.28%
2008 -NZ$34.98 Million-8.03%
2007 -NZ$38.03 Million3.85%
2006 -NZ$36.62 Million39.31%
2005 -NZ$26.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.39 Billion 9,202.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.8 Million 637.75%๐Ÿ‡บ๐Ÿ‡ธ USA